An official website of the United States government

Here's how you know

Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

COVID-19

Expand for resources

PAR-22-089 - Development of Biomarkers or Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 4

Active NOSIs

Title	Notice Number	Organization	Release Date	Expiration Date	Activity Code(s)
Notice of Special Interest (NOSI): Advancing Research for Amyotrophic Lateral Sclerosis (ALS)	NOT-NS-23-062	NINDS	Feb 6, 2023	Jun 24, 2023	R61/R33, R41/R42, R43/R44
Notice of Special Interest: Biomarker Discover and Validation in Functional Neurological Disorders	NOT-NS-22-010	NINDS	Oct 1, 2021	Jan 8, 2025	R61/R33, U01, U44

Title	Notice Number	Organization	Release Date	Expiration Date	Activity Code(s)
Notice of Special Interest (NOSI) in Migraine and Headache Research	NOT-NS-22-051	NINDS	Dec 27, 2021	May 8, 2022	U01, K01, UG3/UH3, K22, K99/R00, K02, K08, R01, F30, K23, F32, R21, F31, R61/R33
Notice of Special Interest (NOSI) in NINDS mission relevant Pain Research	NOT-NS-22-050	NINDS	Dec 27, 2021	May 8, 2022	K01, UG3/UH3, K99/R00, K22, K08, R01, K02, F30, K23, R21, F32, F31, U01, U24, R61/R33